M J Flens

2.6k total citations · 1 hit paper
25 papers, 2.2k citations indexed

About

M J Flens is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M J Flens has authored 25 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 9 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M J Flens's work include Drug Transport and Resistance Mechanisms (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Gastric Cancer Management and Outcomes (4 papers). M J Flens is often cited by papers focused on Drug Transport and Resistance Mechanisms (17 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Gastric Cancer Management and Outcomes (4 papers). M J Flens collaborates with scholars based in Netherlands, Spain and United States. M J Flens's co-authors include G J Zaman, Rik J. Scheper, Marcel de Haas, Miguel Izquierdo, George L. Scheffer, Herbert M. Pinedo, Paul van der Valk, Anouk B. Schroeijers, Frank Baas and J. Lankelma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

M J Flens

24 papers receiving 2.2k citations

Hit Papers

The human multidrug resistance-associated protein MRP is ... 1994 2026 2004 2015 1994 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J Flens Netherlands 17 1.8k 873 565 483 233 25 2.2k
HJ Broxterman Netherlands 19 1.9k 1.1× 1.1k 1.2× 599 1.1× 403 0.8× 285 1.2× 27 2.5k
G J Zaman Netherlands 10 2.1k 1.2× 910 1.0× 805 1.4× 526 1.1× 313 1.3× 10 2.5k
Jane E. Mackie Canada 8 2.3k 1.3× 1.2k 1.4× 715 1.3× 462 1.0× 392 1.7× 13 2.8k
H J Broxterman Netherlands 21 1.7k 1.0× 1.2k 1.4× 434 0.8× 269 0.6× 223 1.0× 27 2.4k
R J Scheper Netherlands 17 1.8k 1.0× 834 1.0× 583 1.0× 448 0.9× 262 1.1× 27 2.6k
Lyn A. Mickley United States 19 1.9k 1.0× 1.2k 1.3× 500 0.9× 389 0.8× 327 1.4× 24 2.3k
Donglai Shen China 19 1.7k 1.0× 1.6k 1.8× 280 0.5× 382 0.8× 254 1.1× 38 2.6k
Zhirong Zhan United States 21 1.8k 1.0× 1.6k 1.8× 438 0.8× 255 0.5× 261 1.1× 33 2.8k
E Schneider United States 17 1.1k 0.6× 1.0k 1.2× 253 0.4× 170 0.4× 175 0.8× 21 1.8k
G L Scheffer Netherlands 13 1.3k 0.7× 780 0.9× 308 0.5× 274 0.6× 167 0.7× 14 1.7k

Countries citing papers authored by M J Flens

Since Specialization
Citations

This map shows the geographic impact of M J Flens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J Flens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J Flens more than expected).

Fields of papers citing papers by M J Flens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J Flens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J Flens. The network helps show where M J Flens may publish in the future.

Co-authorship network of co-authors of M J Flens

This figure shows the co-authorship network connecting the top 25 collaborators of M J Flens. A scholar is included among the top collaborators of M J Flens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J Flens. M J Flens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flens, M J, et al.. (2017). Extramural Venous Invasion as Prognostic Factor of Recurrence in Stage 1 and 2 Colon Cancer. Gastroenterology Research and Practice. 2017. 1–6. 11 indexed citations
2.
Loffeld, R. J. L. F., Pascale E. P. Dekkers, & M J Flens. (2013). The Incidence of Colorectal Cancer Is Decreasing in the Older Age Cohorts in the Zaanstreek Region in the Netherlands: An Age-Cohort Effect. SHILAP Revista de lepidopterología. 2013. 1–5. 3 indexed citations
3.
Flens, M J, et al.. (2009). Collagenous colitis: Description of a single centre series of 83 patients. European Journal of Internal Medicine. 20(5). 499–502. 16 indexed citations
4.
Flens, M J, et al.. (2009). Calciphylaxis in chronic renal failure: An approach to risk factors. Indian Journal of Nephrology. 19(3). 115–115. 5 indexed citations
5.
Lier, Margot G F van, et al.. (2005). Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia. Journal of Clinical Pathology. 58(7). 722–724. 8 indexed citations
6.
Scheffer, G L, Mariska C. de Jong, A Monks, et al.. (2002). Increased expression of beta 2-microglobulin in multidrug-resistant tumour cells. British Journal of Cancer. 86(12). 1943–1950. 13 indexed citations
7.
Meijer, Gerrit A., Anouk B. Schroeijers, M J Flens, et al.. (1999). Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis.. Journal of Clinical Pathology. 52(6). 450–454. 45 indexed citations
8.
Schroeijers, Anouk B., G L Scheffer, M J Flens, et al.. (1998). Immunohistochemical detection of the human major vault protein LRP with two monoclonal antibodies in formalin-fixed, paraffin-embedded tissues.. PubMed. 152(2). 373–8. 21 indexed citations
10.
Nooter, Kees, Guy Brutel de la Rivière, Maxime P. Look, et al.. (1997). The prognostic significance of expression of the multidrug resistance-associated protein (MRP) in primary breast cancer. British Journal of Cancer. 76(4). 486–493. 116 indexed citations
11.
Dolfini, E., Teresa Dasdia, Giuseppe Arancia, et al.. (1997). Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. British Journal of Cancer. 76(1). 67–76. 29 indexed citations
12.
Blom, Daniël, M J Flens, Gré P.M. Luyten, et al.. (1997). Multidrug resistance-related proteins in primary choroidal melanomas and in vitro cell lines.. PubMed. 38(12). 2523–30. 16 indexed citations
13.
Boer, Monique L. den, C. Michel Zwaan, R. Pieters, et al.. (1997). Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia. Leukemia. 11(7). 1078–1085. 41 indexed citations
14.
Flens, M J, G J Zaman, Paul van der Valk, et al.. (1996). Tissue distribution of the multidrug resistance protein.. PubMed. 148(4). 1237–47. 406 indexed citations
15.
Izquierdo, Miguel, George L. Scheffer, M J Flens, et al.. (1996). Major vault protein LRP-related multidrug resistance. European Journal of Cancer. 32(6). 979–984. 82 indexed citations
16.
Nooter, Kees, Fred T. Bosman, Henry Burger, et al.. (1996). Expression of the multidrug resistance-associated protein (MRP) gene in primary non-small-cell lung cancer. Annals of Oncology. 7(1). 75–81. 60 indexed citations
17.
Neefjes, Jacques, et al.. (1996). Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines. British Journal of Cancer. 74(12). 1961–1967. 39 indexed citations
18.
Zaman, G J, Marcel de Haas, C. H. M. Versantvoort, et al.. (1995). Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. British Journal of Cancer. 72(2). 298–306. 19 indexed citations
19.
Schadendorf, Dirk, et al.. (1995). Membrane transport proteins associated with drug resistance expressed in human melanoma.. PubMed. 147(6). 1545–52. 72 indexed citations
20.
Vermorken, Jan B., Paul van der Valk, Jeroen A.M. Beliën, et al.. (1995). Drug Resistance-Associated Marker Lrp for Prediction of Response to Chemotherapy and Prognoses in Advanced Ovarian Carcinoma. JNCI Journal of the National Cancer Institute. 87(16). 1230–1237. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026